Resumo

GRANDA-LOBATO, P; PEDRAZA-NIETO, L; APARICIO-HERNANDEZ, R  e  GARCIA-LUQUE, A. Positive assessment of drugs: January, February, March 2020. Sanid. Mil. [online]. 2020, vol.76, n.3, pp.173-176.  Epub 08-Mar-2021. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712020000300006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in April and June of 2020, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Bempedoic Acid, Nilemdo®; Bempedoic Acid/Ezetimibe, Nustendi®; Cefiderocol, Fetcroja®; Crisaborole, Staquis®; Darolutamide, Nubeqa®; Givosiran, Givlaari®; Indacaterol/mometasone, Atectura Breezhaler®, Bemrist Breezhaler®; Insulin Lispro, Liumjev®; Isatuximab, Sarclisa®; Onasmnogene Abeparvovec, Zolgensma®; Ozanimod, Zeposia®; Pretomanid, Pretomanid Fgk®; Semaglutide, Rybelsus®; Treprostinil sodium, Trepulmix®; Influenza Vaccine, Fluad Tetra®; Cholera Vaccine, Vaxchora®.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )